[Medical treatment for Cushing's syndrome].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nihon rinsho. Japanese journal of clinical medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18186263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Update on Medical Treatment of Cushing’s Syndrome

  2025cites this paper
• Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms

  2025influential citation
• Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies

  2023cites this paper
• Treatment of Pituitary and Other Tumours with Cabergoline: New Mechanisms and Potential Broader Applications

  2019cites this paper
• Cabergoline use for cushing’s disease during pregnancy: Mini review

  2017cites this paper
• Pharmacological Management of Cushing ’ s Disease

  2017cites this paper
• Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds

  2017cites this paper
• Le syndrome de cushing chez l'adolescent: à propos de 18 patients

  2015cites this paper
• The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy

  2014influential citation
• Treatment of Cushing's disease: a mechanistic update.

  2014cites this paper
• A case of ectopic ACTH syndrome treated with intermittent administration of dopamine agonists

  2014cites this paper
• Chapter 29 Multimodality Treatment of Pituitary Adenomas

  2014cites this paper
• Characterization of persistent and recurrent Cushing’s disease

  2014cites this paper
• Mifepristone: is there a place in the treatment of Cushing’s disease?

  2013influential citation
• Remission with Cabergoline in Adolescent Boys with Cushing’s Disease

  2013cites this paper
• Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.

  2013cites this paper
• Cushing ’ s syndrome – An update in diagnosis and management

  2013cites this paper
• The Therapy of Cushing’s Disease in Adults and Children: An Update

  2012cites this paper
• Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing’s disease

  2012cites this paper
• The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome

  2012cites this paper
• Medical management of Cushing’s disease: what is the future?

  2012influential citation
• Pituitary Disorders

  2012influential citation
• ICA Occlusion by an ACTH-secreting pituitary adenoma post-TSS and irradiation

  2011cites this paper
• Adrenocortical carcinoma: a clinician's update

  2011cites this paper
• Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas

  2010influential citation
• Pasireotide for the treatment of Cushing's disease

  2010cites this paper
• Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone

  2010cites this paper
• Cabergoline monotherapy in the long-term treatment of Cushing's disease.

  2010cites this paper
• Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

  2010cites this paper
• Merits and pitfalls of mifepristone in Cushing's syndrome.

  2009cites this paper
• Medical therapy of pituitary adenomas: Effects on tumor shrinkage

  2009cites this paper
• Pituitary-directed medical treatment of Cushing’s disease

  2009cites this paper
• Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome

  2009cites this paper
• Hypokalemia, metabolic alkalosis, and hypertension in a lung cancer patient.

  2009cites this paper
• Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.

  2009cites this paper
• Advances in the medical management of Cushing's syndrome

  2008cites this paper
• Hypophosphatemia as Unusual Cause of ARDS in Cushing’s Syndrome Secondary to Ectopic CRH Production. A Case Report

  2008cites this paper
• Somatostatin and somatostatin receptors in Cushing's disease.

  2008cites this paper
• The Ectopic Adrenocorticotropic Hormone Syndrome in Carcinoid Tumors

  2008cites this paper
• Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

  2008cites this paper
• Síndrome de Cushing primario. Aspectos controvertidos

  2008cites this paper
• Pituitary-targeted medical therapy of Cushing's disease

  2008cites this paper
• Adénome corticotrope

  2008influential citation
• Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances

  2008cites this paper
• Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease.

  2008influential citation
• Medical Therapy for Cushing’s Disease – Past and Future Modes of Treatment

  2008cites this paper
• Medical management of Cushing disease.

  2007cites this paper
• Successful remission using metyrapone in an elderly patient with Cushing disease accompanied by generalized edema

  2007cites this paper
• Long-Term Treatment of Central Cushing's Syndrome with Rosiglitazone

  2007cites this paper
• Cyclic Cushing's syndrome: an overview.

  2007cites this paper
• Cyclic Cushing’s Syndrome: An Overview

  2007cites this paper
• Dopamine receptor expression and function in corticotroph ectopic tumors.

  2007cites this paper
• Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful

  2007cites this paper
• Advances in medical treatment of Cushing’s disease

  2007cites this paper
• Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas.

  2007cites this paper
• Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas.

  2007cites this paper
• Bromocriptine-responsive Cushing's disease; clinical and biochemical remission accompanied by amelioration of impaired ocular movement.

  2007influential citation
• Treatment options for Cushing disease after unsuccessful transsphenoidal surgery.

  2007cites this paper
• Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action.

  2006cites this paper
• Long term control of hypercortisolism with fluconazole: case report and in vitro studies.

  2006cites this paper
• Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease

  2006cites this paper
• Treatment of ACTH-Inde- Adrenocortical Hyperplasia

  2006cites this paper
• Novel therapeutic directions in Cushing’s syndrome

  2006cites this paper